A Rare Case of Coexisting Breast Cancer and Refractory Acute Myeloid Leukemia.
Laura BallottaS M TrisoliniA P IoriU La RoccaA MicozziG GentileT De GiacomoA GuariniR FoàS CapriaPublished in: Case reports in hematology (2020)
The occurrence of acute myeloid leukemia (AML) within six months from a diagnosis of breast cancer (BC) is rarely reported in the literature, and it is associated with a poor prognosis. We report herein the case of a 40-year-old woman referred to our centre affected by BC and simultaneous AML. The patient proved refractory to first line therapy and achieved complete remission (CR) with a clofarabine-based regimen followed by allogeneic stem cell transplantation (ASCT). Both during salvage chemotherapy and after ASCT, the patient presented severe infectious complications ( acute cholecistytis and Nocardia pneumonia, respectively) treated with surgery, and currently she is alive in CR for both diseases after 29 months of follow-up. The case highlights the importance of a diagnostic assessment of any unexplained cytopenia in association with solid neoplasia under treatment, underlining the feasibility and priority of a timely treatment of the haematological neoplasm in order to achieve long-term survival.
Keyphrases
- acute myeloid leukemia
- stem cell transplantation
- poor prognosis
- rare case
- high dose
- allogeneic hematopoietic stem cell transplantation
- long non coding rna
- systematic review
- case report
- risk assessment
- minimally invasive
- respiratory failure
- high grade
- early onset
- radiation therapy
- combination therapy
- drug induced
- replacement therapy
- mesenchymal stem cells
- smoking cessation
- young adults
- cell therapy
- hematopoietic stem cell
- acute respiratory distress syndrome